Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
GILEAD SCIENCES, INC. | Chief Commercial Officer | Common Stock | 73.1K | $6.68M | $91.28 | Nov 6, 2024 | Direct |
GILEAD SCIENCES, INC. | Chief Commercial Officer | Restricted Stock Unit | 39.9K | $3.25M | $81.44 | Sep 10, 2024 | Direct |
GILEAD SCIENCES, INC. | Chief Commercial Officer | Restricted Stock Unit | 43.7K | $2.85M | $65.25 | Jun 10, 2024 | Direct |
NEUROCRINE BIOSCIENCES INC | Director | Common Stock | 2.1K | $295K | $140.24 | May 17, 2024 | Direct |
NEUROCRINE BIOSCIENCES INC | Director | Non-Qualified Stock Option | 2.98K | $219K | $73.60 | May 22, 2024 | Direct |
NEUROCRINE BIOSCIENCES INC | Director | Restricted Stock Unit | 1.44K | $204K | $141.90 | May 22, 2024 | Direct |
Arcus Biosciences, Inc. | Director | Common Stock | 0 | $0 | $21.00 | Jan 29, 2024 | Direct |
GILEAD SCIENCES, INC. | Chief Commercial Officer | Non-qualified Stock Option (Right to Buy) | 88K | Mar 10, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
GILD | GILEAD SCIENCES, INC. | Nov 6, 2024 | 1 | -$456K | 4 | Nov 7, 2024 | Chief Commercial Officer |
GILD | GILEAD SCIENCES, INC. | Sep 12, 2024 | 2 | -$2.46M | 4 | Sep 13, 2024 | Chief Commercial Officer |
GILD | GILEAD SCIENCES, INC. | Sep 10, 2024 | 3 | -$141K | 4 | Sep 11, 2024 | Chief Commercial Officer |
GILD | GILEAD SCIENCES, INC. | Aug 28, 2024 | 1 | -$742K | 4 | Aug 29, 2024 | Chief Commercial Officer |
GILD | GILEAD SCIENCES, INC. | Aug 13, 2024 | 1 | -$406K | 4 | Aug 14, 2024 | Chief Commercial Officer |
GILD | GILEAD SCIENCES, INC. | Jun 10, 2024 | 3 | -$112K | 4 | Jun 11, 2024 | Chief Commercial Officer |
NBIX | NEUROCRINE BIOSCIENCES INC | May 22, 2024 | 2 | $0 | 4 | May 23, 2024 | Director |
NBIX | NEUROCRINE BIOSCIENCES INC | May 17, 2024 | 2 | $0 | 4 | May 21, 2024 | Director |
GILD | GILEAD SCIENCES, INC. | Mar 10, 2024 | 7 | -$342K | 4 | Mar 11, 2024 | Chief Commercial Officer |
GILD | GILEAD SCIENCES, INC. | Jan 31, 2024 | 3 | -$1.76M | 4 | Feb 2, 2024 | Chief Commercial Officer |
RCUS | Arcus Biosciences, Inc. | Jan 29, 2024 | 0 | $0 | 3 | Feb 7, 2024 | Director |
GILD | GILEAD SCIENCES, INC. | Jan 9, 2024 | 1 | -$702K | 4 | Jan 10, 2024 | Chief Commercial Officer |
GILD | GILEAD SCIENCES, INC. | Dec 10, 2023 | 3 | -$98.5K | 4 | Dec 11, 2023 | Chief Commercial Officer |
GILD | GILEAD SCIENCES, INC. | Sep 10, 2023 | 3 | -$95.5K | 4 | Sep 11, 2023 | Chief Commercial Officer |
GILD | GILEAD SCIENCES, INC. | Jul 24, 2023 | 3 | -$246K | 4 | Jul 25, 2023 | Chief Commercial Officer |
GILD | GILEAD SCIENCES, INC. | Jun 10, 2023 | 3 | -$99.4K | 4 | Jun 12, 2023 | Chief Commercial Officer |
NBIX | NEUROCRINE BIOSCIENCES INC | May 17, 2023 | 2 | $0 | 4 | May 19, 2023 | Director |
GILD | GILEAD SCIENCES, INC. | Mar 10, 2023 | 7 | -$407K | 4 | Mar 13, 2023 | Chief Commercial Officer |
GILD | GILEAD SCIENCES, INC. | Jan 24, 2023 | 3 | -$1.29M | 4 | Jan 26, 2023 | Chief Commercial Officer |
GILD | GILEAD SCIENCES, INC. | Dec 10, 2022 | 3 | -$40.7K | 4 | Dec 13, 2022 | Chief Commercial Officer |
GILD | GILEAD SCIENCES, INC. | Sep 10, 2022 | 3 | -$29.9K | 4 | Sep 12, 2022 | Chief Commercial Officer |
GILD | GILEAD SCIENCES, INC. | Jul 24, 2022 | 3 | -$195K | 4 | Jul 26, 2022 | Chief Commercial Officer |
GILD | GILEAD SCIENCES, INC. | Jun 10, 2022 | 3 | -$28.1K | 4 | Jun 13, 2022 | Chief Commercial Officer |
NBIX | NEUROCRINE BIOSCIENCES INC | May 18, 2022 | 1 | $0 | 4 | May 20, 2022 | Director |
GILD | GILEAD SCIENCES, INC. | Mar 10, 2022 | 7 | -$187K | 4 | Mar 14, 2022 | Chief Commercial Officer |
GILD | GILEAD SCIENCES INC | Jan 26, 2022 | 1 | $0 | 4 | Jan 28, 2022 | Chief Commercial Officer |
GILD | GILEAD SCIENCES INC | Jul 24, 2021 | 3 | -$236K | 4 | Jul 27, 2021 | Chief Commercial Officer |
NBIX | NEUROCRINE BIOSCIENCES INC | May 19, 2021 | 1 | $0 | 4 | May 20, 2021 | Director |